These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 4138741)
1. The pharmacology and clinical evaluation of aprindine a new antiarrhythmic agent. Fasola AF; Carmichael R Acta Cardiol; 1974; Suppl 18():317-33. PubMed ID: 4138741 [No Abstract] [Full Text] [Related]
2. General aspects of anti-arrhythmic treatment with aprindine. Kesteloot H Acta Cardiol; 1974; Suppl 18():303-16. PubMed ID: 4138773 [No Abstract] [Full Text] [Related]
3. Preliminary experience in the treatment of cardiac arrhythmias with aprindine. Bollen G; Enderle J Acta Cardiol; 1974; Suppl 18():355-60. PubMed ID: 4138528 [No Abstract] [Full Text] [Related]
4. [Clinical study of a new anti-arrhythmia agent: aprindine]. Palma-Gamiz JL; Boedo C; Lopez-Pujol FJ; de Uria JS Acta Cardiol; 1974; Suppl 18():361-8. PubMed ID: 4138640 [No Abstract] [Full Text] [Related]
5. Treatment of chronic ventricular dysrhythmias with a new drug: aprindine (AC 1802). Van Durme JP; Rousseau M; Mbuyamba P Acta Cardiol; 1974; Suppl 18():335-40. PubMed ID: 4138863 [No Abstract] [Full Text] [Related]
6. [Effects of aprindine in disorders of the auriculoventricular conduction]. Petit-Guinovart M; Ballesta-Barcons F Acta Cardiol; 1974; Suppl 18():369-87. PubMed ID: 4547427 [No Abstract] [Full Text] [Related]
8. [Anti-arrhythmic efficacy of aprindine during the acute phase of myocardial infarct]. Hagemeijer F; Janse C; Hugenholtz PG Acta Cardiol; 1974; Suppl 18():409-21. PubMed ID: 4138502 [No Abstract] [Full Text] [Related]
9. [Comparison of aprindine (AC 1802) and lidocaine by intravenous route during the acute phase of myocardial infarct]. Depaepe A; Bohyn P; De Maertelaere M; Dernier J; Cloetens W; De Mey D Acta Cardiol; 1974; Suppl 18():423-32. PubMed ID: 4138738 [No Abstract] [Full Text] [Related]
10. [Effects of aprindine (AC 1802) on myocardial function in man]. Besse P; Choussat A Acta Cardiol; 1974; Suppl 18():217-31. PubMed ID: 4547426 [No Abstract] [Full Text] [Related]
12. Therapeutic effectiveness and plasma levels of a new antidysrhythmic drug: aprindine. Van Durme JP; Rosseel T; Bogaert M Acta Cardiol; 1974; Suppl 18():233-4. PubMed ID: 4138126 [No Abstract] [Full Text] [Related]
13. Investigation on the cardiovascular effects of aprindine. Mertens HM; Neuhaus KL Acta Cardiol; 1974; Suppl 18():163-9. PubMed ID: 4547611 [No Abstract] [Full Text] [Related]
14. Therapeutic effectiveness and plasma levels of aprindine, a new antidysrhythmic drug. Van Durme JP; Bogaert MG; Rosseel MT Eur J Clin Pharmacol; 1974 Aug; 7(5):343-6. PubMed ID: 4607575 [No Abstract] [Full Text] [Related]
15. [Toxic and hemodynamic effects of aprindine in the dog. Comparison with other anti-arrhythmia agents]. Lisin N; Carlier J Acta Cardiol; 1974; Suppl 18():117-30. PubMed ID: 4547497 [No Abstract] [Full Text] [Related]
16. [Clinical experiences with a new orally effective antiarrhythmic agent (Aprindin)]. Breithardt G; Gleichmann U; Seipel L; Loogen F Z Kardiol; 1974 May; 63(3):435-44. PubMed ID: 4608660 [No Abstract] [Full Text] [Related]
17. Aprindine (AC 1802), a new anti-arrhythmic drug. Kesteloot H; Van Mieghem W; De Geest H Acta Cardiol; 1973; 28(2):145-65. PubMed ID: 4121909 [No Abstract] [Full Text] [Related]
18. [Panel discussion: Evaluation of the antiarrhythmic drugs and current problems associated with their use in clinical practice (author's transl)]. Acta Cardiol; 1974; Suppl 18():441-58. PubMed ID: 4138236 [No Abstract] [Full Text] [Related]